Infrastrukturprogrammet (RI-programmet) i H2020 har nå en utlysning til samarbeid om utvikling og bedre utnyttelse av nasjonale infrastrukturer;
«INTEGRATING AND OPENING RESEARCH INFRASTRUCTURES OF EUROPEAN INTEREST» (INFRAIA-2016-2017) (såkalte Integrating Actitvities)

Dere som har deltatt tidligere vet at prosjektene som finansieres får midler til tre ulike aktiviteter:

(i) Networking activities, to foster a culture of co-operation between research infrastructures, scientific communities, industries and other stakeholders as appropriate, and to help develop a more efficient and attractive European Research Area;

(ii) Trans-national access or virtual access activities, to support scientific communities in their access to the identified key research infrastructures;

(iii) Joint research activities, to improve, in quality and/or quantity, the integrated services provided at European level by the infrastructures.

Aktivitet (ii), Trans-national access, betyr at konsortiet får tildelt midler som de skal lyse ut for eksterne brukere fra andre land slik at de kan komme og bruke infrastrukturfasilitetene som inngår i prosjektet. Det betyr altså at dere ved å bli med i et slikt prosjekt kan få nye brukere fra andre land til deres infrastruktur.

Utlysningen som nå er åpen har søknadsfrist 30. mars 2016.
Denne utlysningen gjelder det som kalles Advanced Communities, det vil si etablerte nettverk som har mottatt finansiering gjennom dette programmet etter tidligere utlysninger. Utlysningene er derfor rettet mot veldefinerte temaer.

TEMAER I UTLYSNINGEN SOM VI TROR KAN VÆRE AV INTERESSE FOR DERE:

1. Vaccine infrastructures.
This activity aims at bridging the ‘translational gap’ in biomedical research by providing academia- and SME- driven vaccine R&D with high quality services to support vaccine formulation, access to GMP (Good Manufacturing Practices), preclinical studies including relevant animal models, vaccine trials, compilation of regulatory dossiers and advice on production issues like upscale and quality control. Both human and veterinary vaccines, for prophylactic and therapeutic applications, should be addressed. Furthermore, work shall be carried out towards integration with the ESFRI Infrastructures EATRIS and INSTRUCT to ensure sustainability of the trans-national access services. Synergies with other relevant ESFRI Infrastructures, such as ECRIN, should be duly exploited.

2. Experimental facilities for animal disease and infectiology (including zoonoses).
A project under this topic must provide and facilitate access to the key experimental facilities under BSL3 conditions in Europe for animal and zoonotic infectious diseases. It will also include key collections of samples necessary for research on animal and zoonotic infectious diseases. The project should aim to integrate these facilities and resources with a long term perspective. It should also develop the necessary collaborations outside Europe, towards a global sharing of available resources.

3. Centres for replacement, reduction and refinement (3 Rs) of non-human primate testing.
This activity aims at integrating the key non-human primate centres in Europe promoting 3 Rs, i.e. replacement, reduction, and refinement. The proposal will contribute to the objective of 3Rs, reinforcing the implementation of ethical and good practices at European level, and the protection of animals used in scientific experiments, as framed by the directive 86/609/EEC, and by the Commission proposal for its revision, COM(2008)543. The proposal should also develop the necessary collaborations outside Europe.

4. Research Infrastructures for the control of vector-borne diseases.
This activity aims at integrating specialised facilities in Europe for the study of insect-transmitted disease with the objective to validate and roll out new control measures targeting insect vectors that pose the greatest threats to human health and animal industries. These facilities, supporting research and product development, include P3 secure insectaries for research on vectors and pathogens, large scale production of mosquitoes, facilities for the testing and evaluation of insecticides, and facilities for high-throughput genetic analysis of insect vectors and pathogens. The facilities of this activity and associated networking and research activities will play a critical role in consolidating European leadership in the field of insect vector biology and disease control. Synergies with relevant ESFRI Infrastructures such as ELIXIR should be duly exploited.

MERK! Selv om utlysningen gjelder videreføring av tidligere finansierte prosjekter, vil nye miljøer kunne få slippe inn i konsortiene som nå søker, dersom de har relevante infrastrukturfasiliteter å by på. Men det vil nok være lurt å ta kontakt med koordinator for det tidligere finansierte infrastrukturprosjektene. Liste over disse er vedlagt.

NYTTIGE LENKER OG VEDLEGG:
Om RI-programmet: European Research Infrastructures, including e-Infrastructures – European Comission
Her finner dere mer om utlysningen: INFRAIA-01-2016-2017
Forskningsrådets side om infrastrukturprogrammet i H2020: Infrastruktur – HORISONT2020
Informasjon om infrastrukturprosjekter finansiert gjennom FP7 finner dere her: Networks of National Research Infrastructures – Research Infrastructures – Research – European Commission

Vedlagt finner dere arbeidsprogrammet for infrastrukturprogrammet 2016/2017 : Dette beskriver alle delene av infrastrukturprogrammet.

Ta kontakt med RI-NCPene om dere lurer på noe:
Solveig Flock, e-post: sfl@forskningsradet.no
Odd Ivar Eriksen, e-post: oie@forskningsradet.no
Per Magnus Kommandantvold, e-post: pmk@forskningsradet.no